433 related articles for article (PubMed ID: 31582003)
21. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
22. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
23. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
[TBL] [Abstract][Full Text] [Related]
24. Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.
Rodriguez FJ; Scheithauer BW; George D; Midha R; MacCollin M; Stemmer-Rachamimov AO
Acta Neuropathol; 2011 May; 121(5):663-8. PubMed ID: 21191601
[TBL] [Abstract][Full Text] [Related]
25. Pediatric schwannomatosis, a rare but distinct form of neurofibromatosis.
Thomas AK; Egelhoff JC; Curran JG; Thomas B
Pediatr Radiol; 2016 Mar; 46(3):430-5. PubMed ID: 26546566
[TBL] [Abstract][Full Text] [Related]
26. [Segmental schwannomatosis in upper-extremity: 5 cases report and literature review].
Wang ZX; Chen SL; Yi CJ; Li C; Rong YB; Tian GL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):698-703. PubMed ID: 24136261
[TBL] [Abstract][Full Text] [Related]
27. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors.
Strowd RE
Curr Treat Options Oncol; 2020 Aug; 21(10):81. PubMed ID: 32767156
[TBL] [Abstract][Full Text] [Related]
28. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Ahlawat S; Blakeley JO; Langmead S; Belzberg AJ; Fayad LM
Skeletal Radiol; 2020 Feb; 49(2):199-219. PubMed ID: 31396668
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
[TBL] [Abstract][Full Text] [Related]
30. The Neurofibromatoses. Part 1: NF1.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
[TBL] [Abstract][Full Text] [Related]
31. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.
Acar S; Nieblas-Bedolla E; Armstrong AE; Hirbe AC
Pediatr Neurol; 2022 Sep; 134():1-6. PubMed ID: 35759947
[TBL] [Abstract][Full Text] [Related]
33. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
[TBL] [Abstract][Full Text] [Related]
34. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis.
Korf BR
Handb Clin Neurol; 2013; 111():333-40. PubMed ID: 23622184
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous Detection of
Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
[TBL] [Abstract][Full Text] [Related]
37. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Bakker A; Barker A; Clapp W; Ferner R; Fisher MJ; Giovannini M; Gutmann DH; Karajannis MA; Kissil JL; Legius E; Lloyd AC; Packer RJ; Ramesh V; Riccardi VM; Stevenson DA; Ullrich NJ; Upadhyaya M; Stemmer-Rachamimov A
Am J Med Genet A; 2017 Jun; 173(6):1714-1721. PubMed ID: 28436162
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
Ferner RE
Lancet Neurol; 2007 Apr; 6(4):340-51. PubMed ID: 17362838
[TBL] [Abstract][Full Text] [Related]
39. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
[TBL] [Abstract][Full Text] [Related]
40. Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.
Burns R; Niendorf K; Steinberg K; Mueller A; Ly I; Jordan JT; Plotkin SR; Hicks SR
Am J Med Genet A; 2022 Aug; 188(8):2413-2420. PubMed ID: 35638454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
